Canada must not delay action on antimicrobial resistance

Canada is uniquely positioned to act as it prepares to assume the G7 presidency in January 2025.

Antibiotics are a cornerstone of modern medicine. But developing new ones can cost up to $1-billion, and the market does not reflect the unmet needs these novel drugs address, write Bettina Hamelin and Henry Skinner.Photograph courtesy of Pixabay

Opinion

BY BETTINA HAMELIN, HENRY SKINNER

November 25, 2024

Antibiotics are failing. From Vancouver to Vietnam, Montreal to Mumbai, patients are falling ill with untreatable infections caused by bacteria that are resistant to current antibiotics.

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

Top Canadian political and policy opinion and analysis. Saturdays and Sundays. Weekends.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES: